Titan Pharmaceuticals, Inc. (TTNP) Reports Q3 Loss of $0.01
Tweet
Share
E-mailGet Alerts TTNP Hot Sheet
Join SI Premium – FREE
Titan Pharmaceuticals, Inc. (OTCBB: TTNP) reported Q3 EPS of ($0.01), versus ($0.01) reported last year. Revenue for the quarter came in at $1.01 million, versus $3.6 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
